Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amitkumar Mehta

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Postgraduate Medicine|January 8, 2014
Update in systemic therapy of urologic malignanciesDavid Mooney, Ravikumar Paluri, Amitkumar Mehta, et al.
Cancer|October 11, 2018
Congestive heart failure in older adults diagnosed with follicular lymphoma: A population-based studyKelly M Kenzik, Amitkumar Mehta, Joshua S Richman, et al.
Ejhaem|March 5, 2025
Overall and Cause-Specific Mortality Among Patients With Cutaneous T-Cell Lymphoma in the United StatesLauren Shea, Mayur Narkhede, Karthik Chamarti, et al.
Leukemia Research|March 21, 2016
Treatment of CD30-positive systemic mastocytosis with brentuximab vedotinUma Borate, Amitkumar Mehta, Vishnu Reddy, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 22, 2022
Patterns of Utilization and Outcomes of Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Diffuse Large B-cell Lymphomas with MYC and BCL2 and/or BCL6 RearrangementsSean Patrick Bliven, Lauren Shea, Susan Bal, et al.
The American Journal of the Medical Sciences|December 14, 2020
Co-Occurrence of Familial Hemophagocytic Lymphohistiocytosis Type 2 and Chronic Active Epstein-Barr Virus in AdulthoodRichard Curtis Godby, Ryan R Kraemer, Jori May, et al.
Journal of Geriatric Oncology|June 28, 2021
Healthcare utilization and spending among older patients diagnosed with Non-Hodgkin lymphomaKelly M Kenzik, Grant R Williams, Nickhill Bhakta, et al.
Journal of Neuro-Oncology|April 20, 2022
High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictorsAndrew B DeAtkine, Moaaz Abdelrashid, Zach Tucker, et al.
Oncotarget|April 19, 2017
Kinomic profiling identifies focal adhesion kinase 1 as a therapeutic target in advanced clear cell renal cell carcinomaArindam P Ghosh, Christopher D Willey, Joshua C Anderson, et al.
American Journal of Hematology|October 18, 2019
Safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B-cell lymphomaAlex F Herrera, Andre Goy, Amitkumar Mehta, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Postgraduate Medicine|January 8, 2014
Update in systemic therapy of urologic malignanciesDavid Mooney, Ravikumar Paluri, Amitkumar Mehta, et al.
Cancer|October 11, 2018
Congestive heart failure in older adults diagnosed with follicular lymphoma: A population-based studyKelly M Kenzik, Amitkumar Mehta, Joshua S Richman, et al.
Ejhaem|March 5, 2025
Overall and Cause-Specific Mortality Among Patients With Cutaneous T-Cell Lymphoma in the United StatesLauren Shea, Mayur Narkhede, Karthik Chamarti, et al.
Leukemia Research|March 21, 2016
Treatment of CD30-positive systemic mastocytosis with brentuximab vedotinUma Borate, Amitkumar Mehta, Vishnu Reddy, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 22, 2022
Patterns of Utilization and Outcomes of Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Diffuse Large B-cell Lymphomas with MYC and BCL2 and/or BCL6 RearrangementsSean Patrick Bliven, Lauren Shea, Susan Bal, et al.
The American Journal of the Medical Sciences|December 14, 2020
Co-Occurrence of Familial Hemophagocytic Lymphohistiocytosis Type 2 and Chronic Active Epstein-Barr Virus in AdulthoodRichard Curtis Godby, Ryan R Kraemer, Jori May, et al.
Journal of Geriatric Oncology|June 28, 2021
Healthcare utilization and spending among older patients diagnosed with Non-Hodgkin lymphomaKelly M Kenzik, Grant R Williams, Nickhill Bhakta, et al.
Journal of Neuro-Oncology|April 20, 2022
High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictorsAndrew B DeAtkine, Moaaz Abdelrashid, Zach Tucker, et al.
Oncotarget|April 19, 2017
Kinomic profiling identifies focal adhesion kinase 1 as a therapeutic target in advanced clear cell renal cell carcinomaArindam P Ghosh, Christopher D Willey, Joshua C Anderson, et al.
American Journal of Hematology|October 18, 2019
Safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B-cell lymphomaAlex F Herrera, Andre Goy, Amitkumar Mehta, et al.
Pageof 8